Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7287)
All Articles published online
|
Publishing Process of This Article
|
Apr 14, 2017 (publication date) through May 13, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Liu SY, Chen W, Chughtai EA, Qiao Z, Jiang JT, Li SM, Zhang W, Zhang J. PIK3CA gene mutations in Northwest Chinese esophageal squamous cell carcinoma. World J Gastroenterol 2017; 23(14): 2585-2591 [PMID: 28465643 DOI: 10.3748/wjg.v23.i14.2585] |
|---|---|
| URL: | https://www.wjgnet.com/2218-6263/full/v23/i14/2585.htm |
| Number | Citing Articles |
| 1 |
Shutao Zheng, Shuo He, Yan Liang, Yiyi Tan, Qing Liu, Tao Liu, Xiaomei Lu. Understanding PI3K/Akt/mTOR signaling in squamous cell carcinoma: mutated PIK3CA as an example. Molecular Biomedicine 2024; 5(1) doi: 10.1186/s43556-024-00176-0
|
| 2 |
Fernanda Franco Munari, Adriana Cruvinel-Carloni, Croider Franco Lacerda, Antônio Talvane Torres de Oliveira, Cristovam Scapulatempo-Neto, Sandra Regina Morini da Silva, Eduardo Crema, Sheila Jorge Adad, Maria Aparecida Marchesan Rodrigues, Maria Aparecida Coelho Arruda Henry, Denise Peixoto Guimarães, Adhemar Longatto-Filho, Rui Manuel Reis. PIK3CA mutations are frequent in esophageal squamous cell carcinoma associated with chagasic megaesophagus and are associated with a worse patient outcome. Infectious Agents and Cancer 2018; 13(1) doi: 10.1186/s13027-018-0216-3
|
| 3 |
Qingfang Li, Zhihui Li, Ting Luo, Huashan Shi. Targeting the PI3K/AKT/mTOR and RAF/MEK/ERK pathways for cancer therapy. Molecular Biomedicine 2022; 3(1) doi: 10.1186/s43556-022-00110-2
|
| 4 |
Xu Wang, Yaozu Zhu. Circ_0000020 elevates the expression of PIK3CA and facilitates the malignant phenotypes of glioma cells via targeting miR-142-5p. Cancer Cell International 2021; 21(1) doi: 10.1186/s12935-021-01767-5
|
| 5 |
Tomoya Yokota, Masakuni Serizawa, Ayumu Hosokawa, Kimihide Kusafuka, Keita Mori, Toshiro Sugiyama, Yasuhiro Tsubosa, Yasuhiro Koh. PIK3CA mutation is a favorable prognostic factor in esophageal cancer: molecular profile by next-generation sequencing using surgically resected formalin-fixed, paraffin-embedded tissue. BMC Cancer 2018; 18(1) doi: 10.1186/s12885-018-4733-7
|
| 6 |
Donghong Zhang, Haifeng Zhang, Xiaolong Wang, Baoli Hu, Feng Zhang, Haitao Wei, Li Li. LINC01518 knockdown inhibits tumorigenicity by suppression of PIK3CA/Akt pathway in oesophageal squamous cell carcinoma. Artificial Cells, Nanomedicine, and Biotechnology 2019; 47(1): 4284 doi: 10.1080/21691401.2019.1699815
|
| 7 |
Ali Alqahtani, Hazem S. K. Ayesh, Hafez Halawani. PIK3CA Gene Mutations in Solid Malignancies: Association with Clinicopathological Parameters and Prognosis. Cancers 2019; 12(1): 93 doi: 10.3390/cancers12010093
|
| 8 |
Xiaojuan Li, Xinle Tang, Liang Chen, Xingxing Cao, Reziya Ailimujiang, Qian Li, Feicui Zhao. Processed Products of Aconitum soongaricum Stapf. Inhibit the Growth of Ovarian Cancer Cells In vivo via Regulating the PI3K/AKT Signal Pathway. Anti-Cancer Agents in Medicinal Chemistry 2025; 25(9): 630 doi: 10.2174/0118715206344374241219065154
|
| 9 |
Minghao Li, Zicheng Zhang, Qianrong Wang, Yan Yi, Baosheng Li. Integrated cohort of esophageal squamous cell cancer reveals genomic features underlying clinical characteristics. Nature Communications 2022; 13(1) doi: 10.1038/s41467-022-32962-1
|
| 10 |
Md. Arafat Hossain. Targeting the RAS upstream and downstream signaling pathway for cancer treatment. European Journal of Pharmacology 2024; 979: 176727 doi: 10.1016/j.ejphar.2024.176727
|